We were thrilled to welcome Dr. Eliav Barr, Senior VP, Head of Global Clinical Development, and CMO of the pharmaceutical manufacturing company MSD, to Rambam Health Care Campus (Rambam) in Haifa, Israel. His visit underscored our shared commitment to innovation and excellence in clinical trials.
L-R) Tally Lahav (MSD), Miri Goren (MSD), Shiri Fadel, Sagit Gelibter-Niv (MSD), Tali Braun (MSD), Sayeh Ben Arieh (MSD), Professor Michael Halberthal, Dr. Eliav Barr (MSD), and Dr. Avivit Peer. Photography: Rambam HCC
Dr. Barr was captivated by our forward-thinking approach and long-term vision, which extends to 2065. He was particularly impressed by our dedicated clinical research teams and their ability to deliver high-quality research, even in challenging circumstances.
Our tour of the Helmsley Health Discovery Tower and Fortified Underground Emergency Hospital provided a glimpse into our state-of-the-art facilities and our commitment to pushing the boundaries of medical research and clinical trials.
In his conversation with Professor Michael Halberthal, Rambam's Director General, Dr. Barr expressed his admiration for our work, stating, "I look forward to continuing our successful partnership with Rambam and driving groundbreaking advancements in healthcare together. Your dedication is truly inspiring, especially after touring the hospital and experiencing firsthand the challenges you've overcome."
